AIM ImmunoTech Inc.
AIM | AMEX
$0.39
$0.00 (0.00%)
Nov 2, 2026, 10:15 AM ET · Market open
+0.00%
(1D)No price chart data available for 1D timeframe.
Rating
Key Statistics
Market Data
Market Cap $1.33M
1D Range
0.37 0.49
52W Range
0.21 19.74
Valuation (TTM)
PE -0.21
PB 0.62
EV/EBITDA -0.00
Valuation (NTM)
Forward PE N/A
Forward PEG N/A
Price Target N/A
Cash Flow
FCF Yield -872.2%
SBC Adj. FCF Yield -872.2%
SBC Impact N/A
Margins
Gross Margin -133.0%
Operating Margin -10839.4%
FCF Margin -12316.0%
Growth (CAGR)
Revenue 3Y | 5Y -14.5% |
-11.6%
Dil EPS 3Y | 5Y 13.8% |
9.5%
FCF 3Y | 5Y 11.0% |
0.0%
Returns
ROA -154.6%
ROE 261.8%
ROIC -152.1%
Financial Health
Net Cash
$1.41M
Current Ratio 1.01
Interest Coverage -10.27
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United...
Sector Healthcare
Industry Biotechnology
Employees 21
IPO Date Nov 2, 1995
Website aimimmuno.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
May 15, 2026
EPS
-$0.69
Beat +36.11%
YoY:
+86.20% REV
$11K
Beat 0.00%
YoY:
-31.25%Add to Watchlist
Select watchlists to add or remove AIM